Introduced on June 24, 2011 to improve the safety of cosmetics distributed in the US, the Safe Cosmetics Act of 2011 (also known as HR 2359) proposes significant changes to existing legislation for the first time in almost 75 years.
If passed, it will affect cosmetic manufacturers by introducing procedures for new testing, labeling and disclosure requirements.
The Safe Cosmetics Act includes the following key changes:
- Phase-out of ingredients linked to cancer, birth defects and developmental harm
- Creation of a health-based, risk assessment safety standard that includes protections for children, the elderly, workers and other vulnerable populations
- Elimination of labeling loopholes by requiring full ingredient disclosure on product labels and company websites, including salon products and the constituent ingredients of fragrance
- Worker access to information about unsafe chemicals in personal care products
- Mandatory registration and fees for establishments engaged in manufacturing or packaging cosmetics for use in the United States (except for micro-businesses)
- Required data-sharing to avoid duplicate testing and encourage the development of alternatives to animal testing
- Adequate funding to the FDA Office of Cosmetics and Colors so it has the resources it needs to provide effective oversight of the cosmetics industry
In anticipation of the passage of the Safe Cosmetics Act of 2011, Intertek can help you identify any modifications you may need to do to your products and product lines in order to ensure that you will be able to seamlessly comply with no time or money lost. We also offer the following services and more in full preparation for compliance to this act:
- Research & development
- Production & supply chain strategies
- Toxicology assessments
- Label assessments
- Regulatory testing
- GMP testing
Intertek can offer a full suite of solutions for cosmetic regulatory compliance for the US and abroad with over 30,000 experts strategically located where you do business.